5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood. If you want to read our detailed analysis of Wood’s...
Posts Tagged ‘NASDAQ:INCY’
Is INCY Stock A Buy or Sell?
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting...
5 Best Biotech Stocks To Buy For 2021
In this article we discuss the 5 best BioTech stocks to buy for 2021. If you want to read our detailed analysis of the biotech industry, go directly to...
Is INCY A Good Stock To Buy According To Hedge Funds?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms...
Incyte Corporation (INCY) Fell Out Of Favor With Hedge Funds
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Crispin Odey, Toscafund Asset Management, Incyte Corporation (INCY), Intellicheck Inc (IDN), and More
Ackman Wields Finance Tool With Morbid Past for New Venture (Bloomberg) Bill Ackman is putting a modern-day spin on a centuries-old financial innovation...
Were Hedge Funds Right About Incyte Corporation (INCY)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Hedge Funds Souring On Incyte Corporation (INCY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Were Hedge Funds Right About Incyte Corporation (INCY)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Hedge Funds Started Buying Incyte Corporation (INCY) Too Early
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we publish an article with the title “Recession...
How Did Incyte Corporation (INCY) Compare Against Top Hedge Fund Stocks in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft...
Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?
Last year’s fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad...
Were Hedge Funds Right About Dumping Incyte Corporation (INCY)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750...
Here’s What Hedge Funds Think About Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company...
Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due...
Is Incyte Corporation (INCY) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Insider Buying Roundup: Elon Musk Buys Tesla (TSLA) Shares After Earnings Call Backlash
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares...
Wondering What’s Happening in the Financial Markets Today? Take a Look at These 34 Stories!
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
What’s Going On In The Finance World Today?
1. US Stock Market: “U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while...
Why Incyte Corporation (INCY) is in the Spotlight
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $...
11 Fastest Growing S&P 500 Companies in America
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly...
Does Incyte Corporation (INCY) Represent a Good Addition to Your Portfolio?
The market has been volatile due to elections and the potential of another Federal Reserve rate increase. Small cap stocks have been on a tear, as the...
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
10 Most Successful Innovative Companies in The World in 2016
Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these...
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Is Incyte Corporation (INCY) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity...
Hedge Funds Say Just One of These Three Tuesday Movers is Worth Investing In
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation...
Data Show Hedge Funds Like One of these Two Volatile Healthcare Stocks More than the Other
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions...
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares...
The Baker Brothers Cut Their Position in Incyte Corporation
Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million...
Theravance Inc (THRX): Are Hedge Funds Right About This Stock?
Is Theravance Inc (NASDAQ:THRX) a good investment? At the moment, there are many indicators investors can use to analyze stocks. Some of the most under...
Veolia Environnement SA (ADR) (VE), Incyte Corporation (INCY), Cliffs Natural Resources Inc (CLF): 3 Great Downgrades You Should Know About
Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls. Historically, analysts have a tendency to...
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment...
Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only...
Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?
As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of...
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use...
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading...
Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge...
Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week
While the overall market muddled through the past five days, some stocks were on fire. Here are three health-care stocks experiencing humongous gains...
GTx, Inc. (GTXI), Novartis AG (ADR) (NVS): This Week in Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into...
What Hedge Funds Think About Medivation Inc (MDVN)
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets....
Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (...
Incyte Corporation (INCY), Gilead Sciences, Inc. (GILD): Pop-Worthy Data, Incyte, but Let’s See More
The phase 2 data that Incyte Corporation (NASDAQ:INCY) presented on Wednesday was downright stellar. For a subgroup of the patients, the hazard ratio...
MannKind Corporation (MNKD), Incyte Corporation (INCY): Will This Large Biotech Pop Experience Analyst Backlash?
While I do think it’s possible that MannKind Corporation (NASDAQ:MNKD)‘s inhaled insulin device, Afrezza, will be approved by the Food and...
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK...
